Sample reduction strategies in discovery bioanalysis

被引:10
作者
Cai, Xianmei [2 ]
Zhang, Jun [1 ,2 ]
Shou, Wilson Z. [1 ,2 ]
机构
[1] Bristol Myers Squibb, Wallingford, CT 06492 USA
[2] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
关键词
CHROMATOGRAPHY/TANDEM MASS-SPECTROMETRY; LINEAR DYNAMIC-RANGE; CYTOCHROME-P450 INHIBITION ASSAYS; CASSETTE-DOSING PHARMACOKINETICS; DRUG DISCOVERY; LIQUID-CHROMATOGRAPHY; PROTEIN-BINDING; CHEMICAL ENTITIES; LC-MS; QUANTITATIVE BIOANALYSIS;
D O I
10.4155/bio.13.133
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
It is a constant challenge to provide timely bioanalytical support for the evaluation of drug-like properties and PK/PD profiles for the ever-increasing numbers of new chemical entities in a cost-effective manner. While technological advancement in various aspects of LC-MS/MS analysis has significantly improved bioanalytical efficiency, a number of simple sample reduction strategies can be employed to reduce the number of samples requiring analysis, and as a result increase the bioanalytical productivity without deploying additional instruments. In this review, advantages and precautions of common sample reduction strategies, such as sample pooling and cassette dosing, are discussed. In addition, other approaches such as reducing calibration standards and eliminating over-the-curve sample reanalysis will also be discussed. Taken together, these approaches can significantly increase the capacity and throughput of discovery bioanalysis without adding instruments, and are viable means to enhance the overall productivity of the bioanalytical laboratory.
引用
收藏
页码:1691 / 1701
页数:11
相关论文
共 77 条
[1]   Results from a bench marking survey on cassette dosing practices in the pharmaceutical industry [J].
Ackermann, BL .
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2004, 15 (09) :1374-1377
[2]  
Allen MC, 1998, PHARMACEUT RES, V15, P93
[3]   Absorption-excipient-pH classification gradient maps: Sparingly soluble drugs and the pH partition hypothesis [J].
Avdeef, Alex ;
Kansy, Manfred ;
Bendels, Stefanie ;
Tsinman, Konstantin .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 33 (01) :29-41
[4]   Simultaneous pharmacokinetic screening of a mixture of compounds in the dog using API LC/MS/MS analysis for increased throughput [J].
Berman, J ;
Halm, K ;
Adkison, K ;
Shaffer, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) :827-829
[5]  
Bu HZ, 2000, RAPID COMMUN MASS SP, V14, P523, DOI 10.1002/(SICI)1097-0231(20000331)14:6<523::AID-RCM906>3.3.CO
[6]  
2-K
[7]   High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1 [J].
Bu, HZ ;
Magis, L ;
Knuth, K ;
Teitelbaum, P .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2001, 15 (10) :741-748
[8]   Historical review of sample preparation for chromatographic bioanalysis: Pros and cons [J].
Chang, Min S. ;
Ji, Qin ;
Zhang, Jun ;
El-Shourbagy, Tawakol A. .
DRUG DEVELOPMENT RESEARCH, 2007, 68 (03) :107-133
[9]   The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies [J].
Cheung, BWY ;
Cartier, LL ;
Russlie, HQ ;
Sawchuk, RJ .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2005, 19 (03) :347-354
[10]   Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays [J].
Chovan, LE ;
Black-Schaefer, C ;
Dandliker, PJ ;
Lau, YY .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2004, 18 (24) :3105-3112